
|Articles|October 19, 2009
Emerging Pharma Leadership Awards - Michelle Dipp
Advertisement
Michelle Dipp,
VP & Head of US Center of Excellence for External Drug Discovery,
GlaxoSmithKline
Download Adobe Flash Player
“The current economic environment is forcing the industry to adapt and change for the better in order to survive. I believe this will result in survival of the fittest, and biotech will be a source of pride and innovation in the US for decades to come.”Listen to the Podcast for more coverage.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals
3
What Potential Fallout Will MFN Policies Have?
4
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
5




